Adhesive products manufacturer Scapa Group has said it expects its full-year revenues to be ahead of its previous forecast.
However, in a trading update for the half-year to September 30, the group said its revenues for the period were down by around 24 per cent.
Its healthcare revenues were expected to be around 23 per cent less than the year before, while its industrial division revenues are expected to close at 22 per cent less.
Scapa Group said it “has continued to track ahead of its COVID plan.”
“As previously indicated, Scapa acted swiftly to implement structural costs changes across the business in response to the impact of the COVID-19 pandemic on the reduction in product demand, participated in various government assistance programs and ensured variable costs were closely managed to match,” it said.
The group added: “The combination of the better than anticipated business performance in FY21 H1, cost containment actions and continued improvement across both divisions has put the Group on a solid foundation as it enters FY21 H2.”
The group is set to report further details on its full-year trading performance in its interim results on November 17.
